Date Filed | Type | Description |
08/07/2023 |
4
| Lindborg Stacy (Co-CEO) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.
Txns:
| Granted 35,000 shares
@ $0 |
|
08/04/2023 |
4
| Lebovits Chaim (President & CEO) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.
Txns:
| Granted 31,185 shares
@ $0 |
|
05/01/2023 |
4
| Taylor Kirk (Chief Medical Officer) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.
Txns:
| Granted 35,000 shares
@ $0 Granted 80,000 options to buy
@ $2.99, valued at
$239.2k
|
|
05/01/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/04/2023 |
4
| Lindborg Stacy (Co-CEO) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.
Txns:
| Granted 35,000 shares
@ $0 |
|
01/04/2023 |
4
| Lebovits Chaim (CEO) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.
Txns:
| Granted 31,185 shares
@ $0 |
|
04/08/2022 |
4
| FRENKEL JACOB A (Director) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.
Txns:
| Granted 50,000 options to buy
@ $0.75, valued at
$37.5k
|
|
03/14/2022 |
4
| Kern Ralph Dr. (COO and Chief Medical Officer) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.
Txns:
| Granted 35,885 shares
@ $0 |
|
02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/17/2021 |
4
| TAUB MALCOLM S (Director) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.
Txns:
| Granted 12,000 shares
@ $0 |
|
12/17/2021 |
4
| Polverino Anthony J. (Director) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.
Txns:
| Granted 2,000 shares
@ $0 |
|
12/17/2021 |
4
| Almenoff June Sherie (Director) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.
Txns:
| Granted 2,000 shares
@ $0 |
|
12/17/2021 |
4
| Yablonka Uri (Director) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.
Txns:
| Granted 13,333 options to buy
@ $0.75, valued at
$10k
|
|
12/17/2021 |
4
| ARBEL IRIT (Director) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.
Txns:
| Granted 25,333 options to buy
@ $0.75, valued at
$19k
|
|
12/10/2021 |
4
| Kern Ralph Dr. (COO and Chief Medical Officer) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.
Txns:
| Granted 35,885 shares
@ $0 |
|
12/10/2021 |
4
| Lebovits Chaim (CEO) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.
Txns:
| Granted 31,185 shares
@ $0 |
|
12/10/2021 |
4
| TAUB MALCOLM S (Director) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.
Txns:
| Granted 12,000 shares
@ $0 |
|
12/10/2021 |
4
| Polverino Anthony J. (Director) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.
Txns:
| Granted 2,216 shares
@ $0 Granted 2,000 shares
@ $0 |
|
12/10/2021 |
4
| ARBEL IRIT (Director) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.
Txns:
| Granted 25,333 options to buy
@ $0.75, valued at
$19k
|
|
12/10/2021 |
4
| FRENKEL JACOB A (Director) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.
Txns:
| Granted 50,000 options to buy
@ $0.75, valued at
$37.5k
|
|
12/10/2021 |
4
| Abbhi Sankesh (Director) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.
Txns:
| Granted 6,666 shares
@ $0 |
|
12/10/2021 |
4
| Yablonka Uri (Director) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.
Txns:
| Granted 13,333 options to buy
@ $0.75, valued at
$10k
|
|
12/10/2021 |
4
| Almenoff June Sherie (Director) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.
Txns:
| Granted 2,000 shares
@ $0 |
|
11/04/2021 |
3
| Bairu Menghisteab (Director) has filed a Form 3 on BRAINSTORM CELL THERAPEUTICS INC. |
09/02/2021 |
3
| Patlis Alla (See Remarks) has filed a Form 3 on BRAINSTORM CELL THERAPEUTICS INC. |
12/31/2020 |
4
| Shah Preetam (EVP, CFO and Treasurer) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.
Txns:
| Paid exercise price by delivering 25,000 shares
@ $4.64, valued at
$116k
|
|
11/19/2020 |
4
| Lindborg Stacy (EVP, Head Global Clin Research) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.
Txns:
| Bought 200 options to buy
@ $10, valued at
$2k
|
|
09/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/10/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
07/31/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|